Shukun Technology Showcases Clinically Validated 'Digital Doctor' at 2019 World Artificial Intelligence Conference to Drive AI Industrialization in Healthcare

Beijing, August 30 – The Second World Artificial Intelligence Conference was held at the Shanghai Expo Center from August 29 to 31, bringing together more than 300 leading scientists and innovators in the field of artificial intelligence from around the world to showcase new technologies and future application scenarios for AI. Meanwhile, the “2019 Global AI Health Summit,” focusing on AI in healthcare, was also held in Xuhui West Bund, where industry, academia, and research institutions joined forces to explore pathways for the industrialization of AI in healthcare. 

Data shows that the annual growth of medical imaging in China exceeds 30%, while the annual increase in radiologists is only 4%. Senior physicians at primary care levels are even scarcer for complex diseases such as cardiovascular and cerebrovascular disorders. SHUKUN has independently developed original neural networks capable of accurately reconstructing Digital Heart and Digital Brain models, thereby enabling intelligent auxiliary diagnosis for cardiovascular and cerebrovascular diseases. Currently, SHUKUN’s AI-based auxiliary diagnostic products for cardiovascular conditions have been integrated into the routine examination workflows of 180 Grade A tertiary hospitals across China, addressing the diagnosis of coronary heart disease for approximately one-tenth of patients nationwide each year.

Driven by artificial intelligence, China’s healthcare development is shifting from a disease-centered model to a patient-centered one. To achieve large-scale implementation and truly advance the “Healthy China” initiative, medical AI must attain full-scenario coverage and realize industrialized deployment. Currently, SHUKUN has achieved end-to-end, full-scenario coverage for cardiovascular and cerebrovascular AI, encompassing quality control, post-processing, diagnosis, as well as auxiliary diagnostic reporting and film printing. This not only provides patients with efficient, integrated intelligent services but also enables continuous iteration of AI-driven healthcare solutions through real-world use, enhancing their precision and intelligence.

Mao Xinsheng, Chairman of SHUKUN Technology, was invited by the conference to deliver a keynote address. He showcased how “AI data power” reconstructs the “Digital Heart,” enabling the visualization of “medical history,” detection of “lesions,” integration of “morphological and functional diagnosis,” identification of “clinical research questions,” and saving critical “treatment time” for stroke patients. These efforts are dedicated to pioneering the practical implementation of “AI data power” in support of the “Healthy China” initiative.

Three days before the conference, on August 27, the unveiling ceremony of the Clinical Application Center for AI in Cardiovascular Imaging, jointly established by Xi’an Gaoxin Hospital and SHUKUN, was officially held at Xi’an Gaoxin Hospital. At the event, Xi’an Gaoxin Hospital formally announced that SHUKUN’s AI-assisted diagnostic system for coronary CTA had been deployed at the hospital, enabling patients to receive their coronary CTA reports within half a day. Ma Qingjiu, President of Xi’an Gaoxin Hospital, and Ma Chun’e, CEO of SHUKUN, jointly announced the launch of China’s first CCTA screening program for coronary heart disease.

Ma Chun’e, CEO of SHUKUN Technology, stated that in August this year, the State Council issued the “Opinions on Implementing the Healthy China Action,” emphasizing that people’s health is a significant indicator of national prosperity and strength, and that prevention is the most cost-effective and efficient health strategy. The document explicitly called for strengthened prevention and control of major diseases such as cardiovascular and cerebrovascular diseases and cancer. Artificial intelligence (AI) plays a substantial role in this regard. SHUKUN’s coronary artery AI-assisted diagnostic system enables the practical implementation of early screening and prevention without imposing additional burdens on patients, hospitals, or physicians. It effectively applies AI-driven expert experience to primary care settings, thereby benefiting the general public.

It is reported that this Health Forum was jointly organized by the Medical Management Service Guidance Center of the National Health Commission, the China Academy of Information and Communications Technology (CAICT), the Shanghai Municipal Commission of Economy and Informatization, the People’s Government of Xuhui District, and the Internet Healthcare Industry Alliance, with co-organization support from the East China Branch of CAICT. The forum brought together global healthcare giants, local medical AI innovators, and top international experts and scholars, attracting over 600 professional attendees from the healthcare industry. The latest White Paper on Applications of Artificial Intelligence in Medicine will be jointly released by the World Health Organization (WHO) and the International Telecommunication Union (ITU).